---
$id: https://graph.org.ai/products/commodity/51184004
$type: Product
source: UNSPSC
code: "51184004"
title: "Glibenclamide or glyburide"
class: "51184000"
classTitle: "Antidiabetic and hyperglycemic sulfonylureas"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Glibenclamide or glyburide

**UNSPSC Code**: 51184004
**Class**: [Antidiabetic and hyperglycemic sulfonylureas](Antidiabetic and hyperglycemic sulfonylureas.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cation channel blocker and anti-diabetic agent with the molecular formula C23H28ClN3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SX6K58TVWC, chemically known as urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl- but more generally known as glibenclamide, which bears US NIH Compound Identifier 3488. European Medicines Agency schedules Glibenclamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07916MIG WHO schedules glibenclamide in its Anatomical Therapeutic Chemical (ATC) Classification. GLIBENCLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Glibenclamide or glyburide bears US NLM identifiers UMLS ID C0017628 and NCI Concept Code C29076. SMILES: CLC1CC(C(=O)NCCC2CCC(S(=O)(=O)NC(=O)NC3CCCCC3)CC2)C(OC)CC1.

